OBJECTIVE: Universal antenatal screening and intrapartum antibiotic prophylaxis are recommended to prevent perinatal Group B streptococcus (GBS) disease. Vancomycin use is recommended only for women at high risk for beta-lactam anaphylaxis with GBS cultures resistant to clindamycin and erythromycin. We sought to evaluate the use of vancomycin in GBS positive women undergoing vaginal delivery and describe trends over time. STUDY DESIGN: An administrative inpatient database that includes medications was analyzed to evaluate antibiotic use in women admitted for delivery from January 2006 to March 2015. Women were included if they had a vaginal delivery. Primary outcome was receipt of vancomycin by GBS status. Secondary outcomes included trends in vancomycin use, trends in antibiotic use overall among GBS positive women, and types of antibiotics used in this setting. RESULTS: Of 3,758,149 women admitted for vaginal delivery, 655,351 (17.4%) were coded as GBS positive. Of these, 13,215 (2.02%) received vancomycin during their hospitalization. Among GBS positive women the proportion who received vancomycin increased significantly from 0.76% to 3.14% over the study period; use of vancomycin also increased concurrently among GBS negative women from 0.15% to 0.37% (Figure 1) . Overall, 528,335 (80.4%) of GBS positive women received any antibiotic during their hospitalization and the proportion receiving antibiotics decreased significantly from 84.2% in 2006 to 76.0% in 2015. The most common antibiotics administered to GBS positive women undergoing vaginal delivery were penicillin, ampicillin, and erythromycin (Table 1) .
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CONCLUSION:
Use of vancomycin among GBS positive women increased over the study period. This trend may be due to a combination of (i) increased penicillin allergies, (ii) increased antibiotic resistance, and (iii) less frequent testing of antibiotic sensitivities for penicillin-allergic patients. Hospital level systems improvements may be needed to increase obtainment of sensitivities for penicillinallergic women and reduce unnecessary use of this broad spectrum antibiotic.
625 Impact of excess weight gain on risk of postpartum infection in class III obesity OBJECTIVE: Obesity increases postpartum infectious morbidity. However, the impact of gestational weight gain on that risk remains unclear, especially in morbidly obese women. We aimed to assess the impact of gestational weight gain >20 pounds (lbs) (more than Institute of Medicine (IOM) recommendations) on postpartum infectious morbidity in morbidly obese women. STUDY DESIGN: Retrospective cohort of term, non-anomalous singleton pregnancies with maternal body mass index (BMI) !40 at a single institution from 2013-2017. Pregnancies with multiple gestation, late entry to care, and missing weight gain data are excluded. Primary outcome is a composite of postpartum infection (endomyometritis, urinary tract, respiratory, wound) documented >24 hours and <6 weeks postpartum. Secondary outcomes include individual components of composite infection, wound complication, readmission, and blood transfusion. Bivariate statistics compared demographics, pregnancy complications and delivery characteristics of women exceeding the IOM guidelines (GT20) with those who did not (LT20). Multivariable analysis used a stepwise backwardelimination approach, with covariates with p<0.20 retained in final models. RESULTS: Of 374 women, 144 (39%) gained GT20 and 230 (62%) gained LT20. Women in the GT20 group were less likely to be multiparous and less likely to use tobacco (p<0.05). There was no significant difference in other baseline demographics. Median BMI at delivery (49.2 vs 45.7, p<0.01) and median total weight gain (29lbs vs 9lbs, p < 0.01) were both significantly higher in the GT20 group. Among women who gained GT20, 10.4% had postpartum infectious morbidity compared to 3.0% in the LT20 (p<0.01). Wound infection was also significantly more common in the GT20 group (7.6%vs 2%, p¼0.02). After adjustment, women who gained GT20 had a3-fold higher odds of postpartum infectious morbidity (adjusted odds ratio 3.04, 95% confidence interval 1.14, 8.13). CONCLUSION: Women with class III obesity, who gain more weight than the IOM recommends are at increased risk for postpartum infectious morbidity. This further emphasizes the importance of weight gain counseling in this population.
626 Fetus has minimal circulatory enzymatic proteasome activity 
OBJECTIVE:
The constitutive ubiquitin proteasome system is a multicatalytic enzymatic complex with key roles in protein homeostasis and clearance of damaged/misfolded proteins. Cytokines switch the constitutive proteasome (c-PROT) to immunoproteasome (i-PROT), an efficient proteolytic machine with key roles in degradation of microbial proteins and generation of antigenic peptides in infection/inflammation. We sought to characterize the levels and profile of fetal proteasome activities in comparison with amniotic fluid (AF) and maternal blood compartments of pregnancies complicated by intra-amniotic infection (IAI). STUDY DESIGN: We studied AF samples from 126 singleton pregnancies with a clinically indicated amniocentesis to rule-out infection, as follows: +IAI (n¼53, GA: 28AE1 wks), -IAI+PTB (n¼41, GA: 30AE1 wks) and -IAI with term delivery (CRL, n¼22, GA: 30AE1 wks). AF proteasome levels were measured by ELISA for the 20S catalytic subunit (total) or LMP7, the primary subunit of i-PROT. Proteasome total lytic activity was analyzed with fluorogenic substrates targeting caspase-like, chymotrypsin-like and trypsin-like activities. Purified 20S proteasome was used as positive control. Matched AF, maternal blood and cord blood samples from a select group of preterm births with and without IAI, histologic chorioamnionitis and funisitis (n¼3/group) with similar GA at delivery (P¼.278) were analyzed to compare proteasome activities among compartments. RESULTS: IAI was associated with a significant increase in AF immunoreactivity for c-PROT and i-PROT (P<.001-both). Cord blood of fetuses with inflammation showed minimal enzymatic activity for all substrates (Fig. A-D) . When spiked onto 20S proteasome, cord blood (but not maternal blood) had marked proteasomal inhibitory activity irrespective of IAI status. In IAI pregnancies comparison among compartments identified AF had the highest proteasomal activity, followed by maternal blood. The AF i-PROT/c-PROT ratio was increased 88-fold in IAI compared to CRL. Among proteasomal specific activities only trypsin-like and chymotrypsinlike activities were upregulated in AF IAI compared to CRL (P¼.024 and P¼.019, respectively). CONCLUSION: An endogenous proteasomal inhibitor is present in fetal circulation. c-PROT and i-PROT are playing significant roles in protein metabolism and generation of antigenic peptides in AF of gestations complicated by +IAI. OBJECTIVE: Emergency cesarean sections save women's lives but are associated with increased risk of surgical site infection (SSI). Perioperative and operative factors associated with the emergent nature of the procedure increase the risk of SSI. Extended dosing of prophylactic antibiotics is frequently used as one strategy to reduce the increased risk in SSI but pose risks of increasing antimicrobial resistance. This randomized clinical trial study assessed a single dose of antimicrobial prophylaxis versus multiple doses for the prevention of SSI associated with emergency cesarean delivery in Rwanda. STUDY DESIGN: All patients undergoing emergency cesarean section (C/S) in a rural district hospital in Rwanda were assessed for eligibility from 2015 to 2016. Participants were randomized, Group A received one dose of 2 g Ampicillin 15 to 60 minutes prior to skin incision and the group B received 2 g prior to skin incision then extended dosing of 1g Ampicillin every 8 hours over 72 hours. Participants were followed for 30 days post C/S for SSI. Demographic and clinical data were collected by chart review and patient phone interviews were performed on Days 3, 7, 15 and 30.
